 |
SYDNEY, Nov. 29, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to inform stakeholders that the GBM AGILE study in glioblastoma (NCT03970447) has opened at Sunnybrook Health Sciences Centre in Toronto, Ontario. This marks the first Canadian site to open to...
The Victorian Government delegation joined discussions during the visit The first GippsNature product signals a new chapter in Vietnam - Australia dairy ties. A New Cross-Border Dairy Initiative ...
Daily Bulletin
Think outdoor furniture is low-maintenance? Tell that to the sun, the rain, and the occasional possum that decides to test it out. If you’re managing a property, that outdoor setup isn’t just for sho...
Daily Bulletin
Moving to a new home or office can be both exciting and stressful. The process involves a lot of planning, coordination, and effort to ensure that everything runs smoothly. One of the most important d...
Daily Bulletin
